EMA Adopts a Positive Opinion for a New Route of Administration Together with a New Pharmaceutical Form and a New Strength for Isatuximab By Ogkologos - May 8, 2026 150 0 Facebook Twitter Google+ Pinterest WhatsApp It is a cancer medicine used to treat adult patients with multiple myeloma Source RELATED ARTICLESMORE FROM AUTHOR Perioperative Durvalumab Plus FLOT Improves OS in Patients with Resectable Gastric or GEJ Adenocarcinoma Advancing Childhood Cancer Research: A Conversation with Dr. Brigitte Widemann Azacitidine-Venetoclax Prolongs EFS Over Induction Chemotherapy Among Induction-Eligible Patients with AML MOST POPULAR Husband Moved To Tears After Opening Christmas Gift From Wife December 31, 2021 Changes in Metabolism Help Melanomas Spread January 21, 2020 Targeting Inflammation Emerges as a Strategy for Treating Cancer August 19, 2022 Cancer-Free Bell Broken by Excited Patient Who Just Got Done Battling... July 17, 2019 Load more HOT NEWS Facing the future: “How can a 3-year old understand that her... ASCO20 Virtual Research Round Up Podcast: Breast Cancer, Sarcoma, and Supportive... Belzutifan Shows a Significant Benefit Over Everolimus in Patients with Advanced... Tomorrow is National Prescription Drug Take-Back Day!
